Defective p53 results in autophagy induction and chemoresistance to chemotherapeutic agents in colon cancer cells [45], and inhibition of autophagy enhances the sensitivity of colon cancer cells with wild-type p53 to chemotherapeutic agents [46]. This evidence concerns the gene TP53 and malignant colon neoplasm.